HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,692,719 | +12.1% | 130,528 | +6.5% | 0.02% | +16.7% |
Q2 2023 | $10,432,496 | +9.1% | 122,530 | +6.1% | 0.02% | 0.0% |
Q1 2023 | $9,560,091 | +7.4% | 115,532 | +2.1% | 0.02% | -10.0% |
Q4 2022 | $8,903,326 | +17.5% | 113,200 | +10.6% | 0.02% | +17.6% |
Q3 2022 | $7,577,000 | +16.0% | 102,345 | +2.4% | 0.02% | +21.4% |
Q2 2022 | $6,533,000 | +26.2% | 99,921 | +22.5% | 0.01% | +40.0% |
Q1 2022 | $5,178,000 | +22.8% | 81,556 | +2.4% | 0.01% | +25.0% |
Q4 2021 | $4,218,000 | -24.2% | 79,677 | +0.9% | 0.01% | -33.3% |
Q3 2021 | $5,566,000 | +9.6% | 78,957 | +3.4% | 0.01% | +9.1% |
Q2 2021 | $5,078,000 | -19.8% | 76,370 | +34.5% | 0.01% | -31.2% |
Q1 2021 | $6,330,000 | -5.6% | 56,781 | +0.4% | 0.02% | -5.9% |
Q4 2020 | $6,709,000 | +23.6% | 56,541 | -9.1% | 0.02% | +6.2% |
Q3 2020 | $5,428,000 | -78.1% | 62,212 | -77.6% | 0.02% | -79.2% |
Q2 2020 | $24,828,000 | +27.5% | 277,180 | +41.9% | 0.08% | +6.9% |
Q1 2020 | $19,474,000 | -12.2% | 195,335 | +1.2% | 0.07% | +9.1% |
Q4 2019 | $22,185,000 | -10.7% | 193,076 | -1.9% | 0.07% | +3.1% |
Q3 2019 | $24,833,000 | -7.6% | 196,857 | -11.8% | 0.06% | -27.3% |
Q2 2019 | $26,867,000 | +81.3% | 223,274 | +31.8% | 0.09% | +76.0% |
Q1 2019 | $14,819,000 | -0.5% | 169,349 | +28.1% | 0.05% | -5.7% |
Q4 2018 | $14,896,000 | +13.5% | 132,243 | +15.5% | 0.05% | +10.4% |
Q3 2018 | $13,121,000 | +11.0% | 114,513 | -13.1% | 0.05% | +20.0% |
Q2 2018 | $11,824,000 | +1094.3% | 131,850 | +873.4% | 0.04% | +900.0% |
Q1 2018 | $990,000 | +63.4% | 13,545 | +29.7% | 0.00% | +100.0% |
Q4 2017 | $606,000 | +409.2% | 10,442 | +293.1% | 0.00% | – |
Q3 2017 | $119,000 | +54.5% | 2,656 | +35.7% | 0.00% | – |
Q2 2017 | $77,000 | +6.9% | 1,957 | +10.6% | 0.00% | – |
Q1 2017 | $72,000 | -84.4% | 1,769 | -84.6% | 0.00% | -100.0% |
Q4 2016 | $462,000 | +1026.8% | 11,489 | +917.6% | 0.00% | – |
Q3 2016 | $41,000 | -47.4% | 1,129 | -58.2% | 0.00% | – |
Q2 2016 | $78,000 | -40.9% | 2,701 | -28.7% | 0.00% | -100.0% |
Q1 2016 | $132,000 | -97.3% | 3,789 | -97.5% | 0.00% | -96.7% |
Q4 2015 | $4,968,000 | -18.8% | 154,085 | -18.6% | 0.03% | -46.4% |
Q3 2015 | $6,121,000 | -17.5% | 189,390 | +5.5% | 0.06% | -16.4% |
Q2 2015 | $7,423,000 | -7.6% | 179,469 | +0.3% | 0.07% | -4.3% |
Q1 2015 | $8,035,000 | +39.4% | 178,863 | +16.1% | 0.07% | +37.3% |
Q4 2014 | $5,765,000 | – | 154,069 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |